{"id":"NCT00735709","sponsor":"Takeda","briefTitle":"Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder","officialTitle":"A Randomized, Double-blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2009-07","completion":"2009-08","firstPosted":"2008-08-15","resultsPosted":"2013-12-18","lastUpdate":"2013-12-18"},"enrollment":560,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Vortioxetine","otherNames":["Lu AA21004","BrintellixÂ®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Vortioxetine 1 mg","type":"EXPERIMENTAL"},{"label":"Vortioxetine 5 mg","type":"EXPERIMENTAL"},{"label":"Vortioxetine 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the effectiveness and safety of vortioxetine, once daily (QD), in patients with Major Depressive Disorder.","primaryOutcome":{"measure":"Change From Baseline in the 24-item Hamilton Depression Scale Total Score At Week 8","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-11.3,"sd":0.738},{"arm":"Vortioxetine 1 mg","deltaMin":-14.82,"sd":0.745},{"arm":"Vortioxetine 5 mg","deltaMin":-15.42,"sd":0.743},{"arm":"Vortioxetine 10 mg","deltaMin":-16.23,"sd":0.755}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":11},"locations":{"siteCount":48,"countries":["Australia","Czechia","France","Germany","Latvia","Lithuania","Malaysia","Netherlands","Poland","Russia","South Africa","South Korea","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["22901346","27780334"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":140},"commonTop":["Nausea","Headache","Nasopharyngitis","Dizziness","Vertigo"]}}